Structural basis for tunable affinity and specificity of LxCxE-dependent protein interactions with the retinoblastoma protein family.

Rb protein cell-cycle control gene regulation p107 protein protein-protein interactions short linear motif tumor suppressor viral oncogene

Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
01 09 2022
Historique:
received: 08 02 2022
revised: 25 04 2022
accepted: 25 05 2022
pubmed: 19 6 2022
medline: 9 9 2022
entrez: 18 6 2022
Statut: ppublish

Résumé

The retinoblastoma protein (Rb) and its homologs p107 and p130 are critical regulators of gene expression during the cell cycle and are commonly inactivated in cancer. Rb proteins use their "pocket domain" to bind an LxCxE sequence motif in other proteins, many of which function with Rb proteins to co-regulate transcription. Here, we present binding data and crystal structures of the p107 pocket domain in complex with LxCxE peptides from the transcriptional co-repressor proteins HDAC1, ARID4A, and EID1. Our results explain why Rb and p107 have weaker affinity for cellular LxCxE proteins compared with the E7 protein from human papillomavirus, which has been used as the primary model for understanding LxCxE motif interactions. Our structural and mutagenesis data also identify and explain differences in Rb and p107 affinities for some LxCxE-containing sequences. Our study provides new insights into how Rb proteins bind their cell partners with varying affinity and specificity.

Identifiants

pubmed: 35716663
pii: S0969-2126(22)00228-3
doi: 10.1016/j.str.2022.05.019
pmc: PMC9444907
mid: NIHMS1817661
pii:
doi:

Substances chimiques

Repressor Proteins 0
Retinoblastoma Protein 0
Retinoblastoma-Like Protein p130 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1340-1353.e3

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM124148
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM127707
Pays : United States
Organisme : NIGMS NIH HHS
ID : T34 GM007910
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5
pubmed: 20057045
Cell. 1998 Feb 20;92(4):463-73
pubmed: 9491888
Virology. 2009 Feb 20;384(2):274-84
pubmed: 19150725
Nat Rev Cancer. 2002 Dec;2(12):910-7
pubmed: 12459729
J Virol. 1995 Dec;69(12):7791-9
pubmed: 7494290
Nat Rev Cancer. 2018 Jul;18(7):442-451
pubmed: 29692417
Nature. 1991 Jul 18;352(6332):251-4
pubmed: 1857421
Nature. 1998 Feb 5;391(6667):597-601
pubmed: 9468139
Mol Cell Biol. 1999 Oct;19(10):6632-41
pubmed: 10490602
Genes Dev. 2011 Apr 15;25(8):801-13
pubmed: 21498570
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Cell. 2000 Mar 31;101(1):79-89
pubmed: 10778858
Nature. 1998 Feb 5;391(6667):601-5
pubmed: 9468140
Trends Cancer. 2019 May;5(5):308-324
pubmed: 31174843
EMBO J. 2001 Jan 15;20(1-2):295-304
pubmed: 11226179
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
pubmed: 16369096
Cancer Cell. 2002 Aug;2(2):103-12
pubmed: 12204530
Adv Cancer Res. 2001;82:1-54
pubmed: 11447760
Nat Cell Biol. 2005 Apr;7(4):420-8
pubmed: 15750587
Protein Eng Des Sel. 2018 Mar 1;31(3):69-77
pubmed: 29370437
Oncogene. 1993 Nov;8(11):3149-56
pubmed: 8414517
Nat Rev Cancer. 2008 Sep;8(9):671-82
pubmed: 18650841
Anal Biochem. 1992 Aug 15;205(1):65-9
pubmed: 1332537
J Virol. 2006 Jul;80(13):6517-24
pubmed: 16775338
Genes Dev. 2010 Jul 1;24(13):1364-76
pubmed: 20551165
Cell. 1999 Sep 17;98(6):859-69
pubmed: 10499802
J Mol Biol. 2011 Sep 16;412(2):267-84
pubmed: 21787785
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10493-8
pubmed: 9724731
Genes Dev. 2010 Jul 1;24(13):1351-63
pubmed: 20551166
Trends Genet. 1998 Jun;14(6):223-9
pubmed: 9635405
Nat Rev Mol Cell Biol. 2013 May;14(5):297-306
pubmed: 23594950
Cell Commun Signal. 2015 Nov 21;13:43
pubmed: 26589632
Nat Rev Mol Cell Biol. 2008 Sep;9(9):713-24
pubmed: 18719710
Trends Biochem Sci. 2009 Oct;34(10):471-82
pubmed: 19744855
FEBS J. 2010 Feb;277(4):973-88
pubmed: 20088881
Mol Cell. 2019 Mar 7;73(5):985-1000.e6
pubmed: 30711375
Mol Cell. 2011 Aug 19;43(4):663-72
pubmed: 21855804
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
Curr Opin Struct Biol. 2019 Feb;54:26-33
pubmed: 30368054
Mol Cell Biol. 2000 Dec;20(23):8903-15
pubmed: 11073990
Front Mol Biosci. 2020 Jun 16;7:110
pubmed: 32613009
J Mol Biol. 2016 Oct 9;428(20):3960-3971
pubmed: 27567532
J Biol Chem. 2005 Nov 11;280(45):37868-76
pubmed: 16118215
Cell Mol Life Sci. 2019 Dec;76(24):4923-4943
pubmed: 31134302
Biochem J. 2021 Jun 11;478(11):2035-2050
pubmed: 34101805
Cell Cycle. 2012 Sep 1;11(17):3189-98
pubmed: 22895179
Proc Natl Acad Sci U S A. 2017 May 9;114(19):4942-4947
pubmed: 28439018
Genes Dev. 2002 Dec 15;16(24):3199-212
pubmed: 12502741
Mol Cell. 2007 Nov 9;28(3):371-85
pubmed: 17996702
Mol Cell. 2019 May 16;74(4):758-770.e4
pubmed: 30982746
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Chem Biol. 2012 Apr 20;19(4):518-28
pubmed: 22520758
J Biol Chem. 2001 Dec 14;276(50):47733-41
pubmed: 11602581
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Genes Dev. 2012 Jun 1;26(11):1156-66
pubmed: 22569856
Mol Cell Biol. 2000 Dec;20(23):8889-902
pubmed: 11073989
Nucleic Acids Res. 2022 Jan 7;50(D1):D497-D508
pubmed: 34718738
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2363-8
pubmed: 12598654
Biochemistry. 2015 Feb 17;54(6):1390-400
pubmed: 25640033
Trends Biochem Sci. 2013 Jan;38(1):12-9
pubmed: 23218751
Nature. 1998 Feb 26;391(6670):859-65
pubmed: 9495340
J Biol Chem. 1990 Aug 5;265(22):12782-5
pubmed: 2198278
Mol Cell. 2007 May 25;26(4):539-51
pubmed: 17531812
Chem Sci. 2021 Feb 3;12(7):2389-2396
pubmed: 34164003
Nat Rev Mol Cell Biol. 2002 Jan;3(1):11-20
pubmed: 11823794
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2795-800
pubmed: 9501169
Genes Dev. 2015 May 1;29(9):961-74
pubmed: 25917549
PLoS One. 2019 Jan 24;14(1):e0211192
pubmed: 30677073

Auteurs

Sivasankar Putta (S)

Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.

Lucia Alvarez (L)

Instituto de Investigaciones Biotecnológicas (IIBiO-CONICET), Escuela de Bio y Nanotecnologías (EByN), Universidad Nacional de San Martín, Av. 25 de Mayo y Francia, Buenos Aires CP1650, Argentina.

Stephan Lüdtke (S)

Belyntic GmbH, Richard-Willstätter-Str. 11, 12489 Berlin, Germany.

Peter Sehr (P)

Chemical Biology Core Facility, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.

Gerd A Müller (GA)

Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.

Samantha M Fernandez (SM)

Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.

Sarvind Tripathi (S)

Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.

Joe Lewis (J)

Chemical Biology Core Facility, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.

Toby J Gibson (TJ)

Structural and Computational Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.

Lucia B Chemes (LB)

Instituto de Investigaciones Biotecnológicas (IIBiO-CONICET), Escuela de Bio y Nanotecnologías (EByN), Universidad Nacional de San Martín, Av. 25 de Mayo y Francia, Buenos Aires CP1650, Argentina. Electronic address: lchemes@iib.unsam.edu.ar.

Seth M Rubin (SM)

Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA. Electronic address: srubin@ucsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH